Relation of blood cyanide to plasma cyanocobalamin concentration after a fixed dose of hydroxocobalamin in cyanide poisoning. 1995

P Houeto, and J R Hoffman, and M Imbert, and P Levillain, and F J Baud
Laboratoire de Toxicologie, Hôpital Fernand Widal, Paris, France.

Hydroxocobalamin combines with cyanide to form cyanocobalamin. We hypothesised that the amount of cyanocobalamin formed after a fixed dose of hydroxocobalamin given for cyanide poisoning would correlate with initial blood cyanide concentration. We determined blood cyanide concentration in 12 patients exposed to residential fires, and compared this with markers of the amount of cyanocobalamin formed after treatment with 5 g intravenous hydroxocobalamin. All relationships were highly correlated (r2 0.79-0.95), for the whole group, and there appeared to be an almost linear relationship for the 9 patients with initial cyanide concentration below 40 mumol/L. Above this concentration, no further cyanocobalamin was formed from a single 5 g dose of hydroxocobalamin. In one patient with initial blood cyanide concentration of 96 mumol/L, however, plasma cyanocobalamin concentration approximately doubled after a second 5 g dose of hydroxocobalamin. 5 g of hydroxocobalamin appears capable of binding all available cyanide ions for blood cyanide concentrations up to about 40 mumol/L. Beyond this, more hydroxocobalamin must be given for remaining cyanide ions to be bound. This information will allow clinicians to use rapidly measurable plasma cyanocobalamin concentrations to gauge severity of exposure and evaluate adequacy of treatment.

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003486 Cyanides Inorganic salts of HYDROGEN CYANIDE containing the -CN radical. The concept also includes isocyanides. It is distinguished from NITRILES, which denotes organic compounds containing the -CN radical. Cyanide,Isocyanide,Isocyanides
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006879 Hydroxocobalamin Injectable form of VITAMIN B 12 that has been used therapeutically to treat VITAMIN B 12 DEFICIENCY. Hydroxycobalamin,Hydroxo-Cobalamin
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old

Related Publications

P Houeto, and J R Hoffman, and M Imbert, and P Levillain, and F J Baud
October 2004, The American journal of emergency medicine,
P Houeto, and J R Hoffman, and M Imbert, and P Levillain, and F J Baud
January 1994, Journal of analytical toxicology,
P Houeto, and J R Hoffman, and M Imbert, and P Levillain, and F J Baud
September 2012, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences,
P Houeto, and J R Hoffman, and M Imbert, and P Levillain, and F J Baud
December 2012, Clinical toxicology (Philadelphia, Pa.),
P Houeto, and J R Hoffman, and M Imbert, and P Levillain, and F J Baud
January 1988, Journal de toxicologie clinique et experimentale,
P Houeto, and J R Hoffman, and M Imbert, and P Levillain, and F J Baud
January 1996, BMJ (Clinical research ed.),
P Houeto, and J R Hoffman, and M Imbert, and P Levillain, and F J Baud
January 1995, Lancet (London, England),
P Houeto, and J R Hoffman, and M Imbert, and P Levillain, and F J Baud
May 2008, The Annals of pharmacotherapy,
Copied contents to your clipboard!